The bone morphogenetic protein (BMP) signaling pathway, especially BMPR2, has long been implicated in PAH with loss-of-function and mutation of BMPR2 function induced by genetic or acquired mechanisms [112]. Here, BMPR2 is linked to pulmonary arterial hypertension.